Prothena Corporation plc (PRTA) saw an uptrend of 2.37% in the recent trading with $6.47 being its most recent. The current price level -74.55% lower than the highest price of $25.42 marked by the stock while trading over the past 52-weeks, whereas it is 49.77% higher than the lowest price of $4.32 the company dropped to over past 52-weeks. The latest news story on PRTA appeared in (Zacks) under the title “AstraZeneca’s AL Amyloidosis Drug Misses Goal in Late-Stage Studies” on Today.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Moderate Buy by 15 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.12 for the stock.
Prothena Corporation plc Earnings – What Happened With PRTA
Coming around sales and income figures on PRTA Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Prothena Corporation plc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 53.83 million. PRTA does have institutional investors; and they hold 70.26% of the stock.
As on 2024-06-30, ECOR1 CAPITAL, LLC was the top most holder in Prothena Corporation plc (NASDAQ:PRTA) with an ownership of 11.58 million shares of the company or 21.5453 of the stake worth $239.1 million. The filing also reveals FMR LLC as the second largest holder in the company with a control over 15.0012 of the outstanding shares. Its stake is worth $166.48 million for having 8.07 million shares in hand.
PRICE T ROWE ASSOCIATES INC /MD/ also came holding a key position in the company during the recent quarter and it now holds 7.881 of the outstanding shares. With this there are now 240.0 institutions which have possession in PRTA’s shares.
Key Metrics forPRTA
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Prothena Corporation plc has a debt to equity ratio of 0.02.
